Clinical Study
Methotrexate-Associated Nonalcoholic Fatty Liver Disease with Transaminitis in Rheumatoid Arthritis
Table 2
Multivariate analysis of independent prediction of NAFLD with transaminitis.
| Variable | Odds ratio | value | 95% confidence interval | Lower | Upper |
| Cumulative methotrexate | 1.035 | 0.015 | 0.092 | 1.051 | Methotrexate dose | 0.944 | 0.337 | 0.840 | 1.062 | Fasting blood Sugar | 0.564 | 0.129 | 0.270 | 1.180 |
|
|